Therapeuticsmd Inc (TXMD)

May 15, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World

May 15, 2025

May 15, 2025

TherapeuticsMD Reports Improved Q1 2025 Results - TipRanks

May 15, 2025

May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results | - GuruFocus

May 14, 2025

May 14, 2025

TherapeuticsMD: Q1 Earnings Snapshot - CT Insider

May 14, 2025

May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results - BioSpace

May 14, 2025

May 13, 2025

TherapeuticsMD Inc Reports Q1 2025 Results: EPS at -$0.06, Reven - GuruFocus

May 13, 2025

May 13, 2025

TherapeuticsMD Reports Q1 2025 Financial Results - TipRanks

May 13, 2025

May 13, 2025

TherapeuticsMD Q1 Operating Expenses USD 1.264 Million - marketscreener.com

May 13, 2025

May 12, 2025

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World

May 12, 2025

May 04, 2025

Today's Dead Cat Bounce Stock: TherapeuticsMD (TXMD) - TheStreet

May 04, 2025

Apr 29, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

Apr 29, 2025

Apr 28, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 28, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 23, 2025

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 23, 2025

Apr 23, 2025

TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World

Apr 23, 2025

Apr 21, 2025

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 21, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock - Investing.com

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock - Investing.com

Apr 15, 2025

Apr 11, 2025

INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025

Apr 11, 2025

DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025

Apr 10, 2025

Mayne Pharma Faces Legal Challenge from TherapeuticsMD - TipRanks

Apr 10, 2025

Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock By Investing.com - Investing.com India

Apr 10, 2025

Apr 09, 2025

TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 09, 2025

Apr 09, 2025

TherapeuticsmdFiles Lawsuit Against Mayne Pharma For Breach Of Contract - marketscreener.com

Apr 09, 2025

Apr 04, 2025

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 04, 2025

Apr 03, 2025

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 03, 2025